Evogene Ltd. (EVGN) — Institutional Holders, Q2 2026

14 institutional investment managers reported a EVGN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $75.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

EVGN in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

3

Added to

2

Trimmed

4

Sold out

5

Biggest buyers

  1. SUSQUEHANNA INTERNATIONAL GROUP, LLPNew · +80,078 sh+$35.1K
  2. CITADEL ADVISORSNew · +50,526 sh+$22.2K
  3. XTX Topco LtdAdded · +6,683 sh+$2.9K
  4. UBS Group AGAdded · +4,438 sh+$1.9K

Biggest sellers

  1. ARMISTICE CAPITALSold out · -456,587 sh-$200.4K
  2. JANE STREET GROUPSold out · -18,500 sh-$8.1K
  3. TWO SIGMA SECURITIESSold out · -12,465 sh-$5.5K
  4. BNP PARIBAS FINANCIAL MARKETSTrimmed · -6,294 sh-$2.8K
  5. MORGAN STANLEYTrimmed · -2,566 sh-$1.1K

EVGN 13F holders ranked 1–14 of 14

Institutional investors reporting a position in Evogene Ltd. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
SUSQUEHANNA INTERNATIONAL GROUP, LLP#1 · 80,078 sh$33.9KNew
CITADEL ADVISORS#2 · 50,526 sh$21.4KNew
XTX Topco Ltd#3 · 19,404 sh$8.2K+52.5%
UBS Group AG#4 · 10,790 sh$4.7K+69.9%
Daytona Street Capital#5 · 9,253 sh$4.7K-3.5%
BNP PARIBAS FINANCIAL MARKETS#6 · 2,830 sh$1.2K-69.0%
MORGAN STANLEY#7 · 1,285 sh$564.00-66.6%
Federation des caisses Desjardins du Quebec#8 · 500 sh$220.000.0%
HRT FINANCIAL#9 · 107,198 sh$45.00New
OSAIC#10 · 100 sh$44.000.0%
SHP Wealth Management#11 · 65 sh$29.000.0%
SBI Securities , Ltd.#12 · 62 sh$27.00-13.9%
ROYAL BANK OF CANADA#13 · 42 sh$0.000.0%
CITIGROUP#14 · 0 sh$0.00New

Funds that sold out of EVGN in Q2 2026 (5)

Held EVGN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held EVGN in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
ARMISTICE CAPITAL456,587 sh$351.6K
JANE STREET GROUP18,500 sh$14.2K
TWO SIGMA SECURITIES12,465 sh$9.6K
Steward Partners Investment Advisory505 sh$389.00
Tradewinds Capital Management131 sh$101.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.